Product Name: BCL11B Antibody
Species Reactivity: Human
Tested Applications: WB
Applications: For WB starting dilution is: 1:16000
User Note: Optimal dilutions for each application to be determined by the researcher.
Predicted Molecular Weight: 96 kDa
Immunogen: This BCL11B antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 307-334 amino acids from the Central region of human BCL11B.
Host Species: Rabbit
Purification: This antibody is purified through a protein A column, followed by peptide affinity purification.
Physical State: Liquid
CAS NO.: 3819-00-9
Product: Piperacetazine
Buffer: Supplied in PBS with 0.09% (W/V) sodium azide.
Concentration: 0.5 mg/ml
Storage Conditions: Store at 4˚C for three months and -20˚C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.
Clonality: Polyclonal
Conjugate: Unconjugated
Alternate Names: B-cell lymphoma/leukemia 11B, BCL-11B, B-cell CLL/lymphoma 11B, COUP-TF-interacting protein 2, Radiation-induced tumor suppressor gene 1 protein, hRit1, BCL11B, CTIP2, RIT1
Accession NO.: Q9C0K0
Protein Ino: 44887723
Official Symbol: BCL11B
Geneid: 64919
Background: This gene encodes a C2H2-type zinc finger protein and isclosely related to BCL11A, a gene whose translocation may beassociated with B-cell malignancies. The specific function of thisgene has not yet been determined. Two alternatively splicedtranscript variants, which encode distinct isoforms, have beenreported.
PubMed ID:http://aac.asm.org/content/53/12/5173.abstract
